Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4564313
Max Phase: Preclinical
Molecular Formula: C32H51N7O6
Molecular Weight: 629.80
Molecule Type: Unknown
Associated Items:
ID: ALA4564313
Max Phase: Preclinical
Molecular Formula: C32H51N7O6
Molecular Weight: 629.80
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C(C)C
Standard InChI: InChI=1S/C32H51N7O6/c1-6-26(40)23(14-10-16-35-31(33)34)36-29(42)25-15-11-17-39(25)30(43)27(21(4)5)38-28(41)24(18-20(2)3)37-32(44)45-19-22-12-8-7-9-13-22/h7-9,12-13,20-21,23-25,27H,6,10-11,14-19H2,1-5H3,(H,36,42)(H,37,44)(H,38,41)(H4,33,34,35)/t23-,24-,25-,27-/m0/s1
Standard InChI Key: QVGZSUPAPQXRIF-XLXZRNDBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 629.80 | Molecular Weight (Monoisotopic): 629.3901 | AlogP: 2.19 | #Rotatable Bonds: 17 |
Polar Surface Area: 195.81 | Molecular Species: BASE | HBA: 7 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.25 | CX Basic pKa: 11.82 | CX LogP: 2.13 | CX LogD: 0.10 |
Aromatic Rings: 1 | Heavy Atoms: 45 | QED Weighted: 0.09 | Np Likeness Score: -0.14 |
1. Hatcher JM, Du G, Fontán L, Us I, Qiao Q, Chennamadhavuni S, Shao J, Wu H, Melnick A, Gray NS, Scott DA.. (2019) Peptide-based covalent inhibitors of MALT1 paracaspase., 29 (11): [PMID:30954428] [10.1016/j.bmcl.2019.03.046] |
Source(1):